KYTOMY

Live / Registered — Registered (as of 10 Nov 2026)

What this means for you

Registered since 10 Nov 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Nov 2032: the §8 declaration of use).

Record

Serial number
97514039
Registration number
8537898
Mark type
Word mark
Filed
21 Jul 2022
Published for opposition
22 Sept 2026
Registered
10 Nov 2026
Next maintenance filing
§8 declaration of use, due by 10 Nov 2032 (grace period to 10 May 2033)
Attorney of record
Makiko Coffland

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the prevention and the treatment of cancer, rare autoimmune diseases and disorders, autoimmune diseases and disorders, liver diseases, biliary diseases, namely bile ducts and gallbladder, metabolic diseases, namely diabetes, hypoglycemia, gout, arthritis, muscular dystrophy and anemia, inflammatory diseases namely, inflammatory bowel diseases, enteric diseases and inflammatory connective tissue diseases, urological diseases, disorders and diseases of the reproductive system namely, sexual reproduction and fertility, puberty diseases or disorders, namely, precocious puberty, gynecological disorders namely, menstrual irregularities and menopause-related diseases and symptoms, namely, anemia, fertility, acromegalia and tumors, hormonal disorders; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management, inflammatory connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, namely, epilepsy, multiple sclerosis, headache, brain tumors, Parkinson's disease, Huntington's disease, Alzheimer's disease, dementia; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome; pharmaceutical preparations and substances for the prevention and treatment of pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin namely, acne, rosacea, dermatitis, psoriasis, vitiligo, hives, alopecia areata, Lupus; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disorders

Owner

Board proceedings on this mark

The owner also pleads this mark in 1 other Board proceeding.

Prosecution history

  • 10 Nov 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 10 Nov 2026 — REGISTERED-PRINCIPAL REGISTER
  • 22 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 22 Sept 2026 — PUBLISHED FOR OPPOSITION
  • 16 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 01 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 31 Aug 2026 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
  • 31 Aug 2026 — CASE RETURNED TO EXAMINATION
  • 31 Aug 2026 — NOTICE OF ALLOWANCE CANCELLED
  • 31 Aug 2026 — SOU EXTENSION 5 GRANTED
  • 24 Feb 2026 — SOU EXTENSION 5 FILED
  • 25 Aug 2026 — ASSIGNED TO PETITION STAFF
  • 20 Jul 2026 — TEAS PETITION TO DIRECTOR RECEIVED
  • 08 Jul 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
  • 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED

View this trademark record on Rightsy